Rosetta Accepting FNA Samples for Analysis with miRNA Lung Cancer Diagnostic

The company said that the move will allow patients to use its miRNA test without having to undergo more invasive procedures to obtain tumor samples.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories